Pharmaniaga Salbutamol Respirator Solution 0.5% w/v

Manufacturer
PHARMANIAGA MANUFACTURING BERHAD
 
Contents
Salbutamol sulfate
 
Indication
Severe bronchospasm.
 
Instruction
Adult: Via nebuliser: 2.5-5 mg, up to 4 times daily, alternatively, may be given continuously at a rate of 1-2 mg/hr.
Child: ≥4 yr Same as adult dose.
 
Drug interaction
Increased risk of hypokalaemia w/ K depleting agents (e.g. corticosteroid, diuretics, xanthines, digoxin). Increased uterine inertia w/ halogenated anaesth (IV). Increased risk of pulmonary oedema w/ corticosteroids. May antagonise the effect of anti-diabetics. Effects may be altered by guanethidine, reserpine, methyldopa, TCAs and MAOIs. Increased risk of CV effects w/ other sympathomimetic agents. Antagonistic effect w/ β-blockers.